Top Page
Wearable Devices Ltd.
(NASDAQ:WLDS)
Wearable Devices Ltd. (WLDS) vs. SPDR S&P 500 ETF (SPY)
Wearable Devices Ltd. Business Overview & Revenue Model
Wearable Devices Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 422.00K | 522.00K | 82.00K | 45.00K | 142.00K | 57.00K |
| Gross Profit | -200.00K | 85.00K | 20.00K | 19.67K | 126.50K | 48.00K |
| EBITDA | -7.26M | -7.71M | -8.12M | -6.43M | -2.60M | -1.15M |
| Net Income | -7.38M | -7.88M | -7.81M | -6.50M | -2.61M | -1.26M |
Balance Sheet | ||||||
| Total Assets | 4.79M | 5.98M | 7.59M | 11.22M | 1.45M | 593.00K |
| Cash, Cash Equivalents and Short-Term Investments | 3.46M | 3.95M | 4.86M | 10.37M | 1.27M | 475.00K |
| Total Debt | 163.00K | 1.08M | 575.00K | 162.00K | 0.00 | 3.05M |
| Total Liabilities | 974.00K | 2.12M | 2.07M | 1.24M | 638.00K | 3.47M |
| Stockholders Equity | 3.81M | 3.86M | 5.53M | 9.98M | 807.00K | -2.88M |
Cash Flow | ||||||
| Free Cash Flow | -6.73M | -7.66M | -8.63M | -5.76M | -2.14M | -1.10M |
| Operating Cash Flow | -6.72M | -7.61M | -8.43M | -5.71M | -2.10M | -1.09M |
| Investing Cash Flow | -1.30M | 3.20M | -4.25M | -66.00K | -36.00K | -16.00K |
| Financing Cash Flow | 6.98M | 6.70M | 3.12M | 14.88M | 2.94M | 0.00 |
Wearable Devices Ltd. Technical Analysis
Wearable Devices Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | $254.92M | -2.05 | -91.95% | ― | -27.37% | 70.46% | |
49 Neutral | $42.18M | -193.53 | -0.69% | ― | 11.58% | 81.08% | |
48 Neutral | $41.97M | -1.87 | -14.35% | ― | 2.35% | 18.83% | |
47 Neutral | $255.60M | -6.86 | -96.37% | ― | -4.31% | 59.68% | |
44 Neutral | $406.04M | -6.88 | -24.39% | ― | 13.27% | -66.48% | |
39 Underperform | $8.60M | -0.16 | -268.12% | ― | -9.05% | 77.41% |
Wearable Devices Ltd. Corporate Events
On December 11, 2025, Wearable Devices Ltd. announced it received a $750,000 grant from the Israel Innovation Authority to fund a clinical pilot program with Soroka University Medical Center. The program aims to validate the Mudra Link neural wristband as a rehabilitation tool for patients with impaired grip-force control due to motor-cortex brain injuries. This initiative underscores the potential of Mudra technology in neurorehabilitation, offering a cost-effective and engaging therapy option that could become the standard of care. The pilot is expected to enhance clinical tools with objective performance metrics, improving treatment accessibility and accelerating recovery for patients with neurological motor deficits.
On November 26, 2025, Wearable Devices Ltd. entered into a warrant inducement agreement with an existing institutional investor for the immediate exercise of warrants to purchase up to 3,322,000 ordinary shares, generating approximately $5.68 million in gross proceeds. The company plans to use the proceeds for working capital and general corporate purposes. In return, the company will issue new warrants to purchase up to 5,813,500 ordinary shares, with an exercise price of $1.86 per share, pending shareholder approval. The transaction is expected to close around December 1, 2025, and is facilitated by A.G.P./Alliance Global Partners as the financial advisor.
On October 29, 2025, Wearable Devices Ltd. announced a Securities Purchase Agreement with an institutional investor for a registered direct offering of ordinary shares and pre-funded warrants, expected to raise approximately $3.3 million. This strategic move aims to bolster the company’s working capital and general corporate purposes, potentially enhancing its market position in the AI-powered wearables industry. The offering includes a concurrent private placement of warrants, subject to shareholder approval, and reflects the company’s ongoing efforts to expand its financial resources and operational capabilities.
On October 24, 2025, Wearable Devices Ltd. held its Annual and Special General Meeting of Shareholders, which was initially delayed due to a lack of quorum but later successfully convened. During the meeting, shareholders approved several key proposals, including amendments to the company’s Compensation Policy and an increase in authorized share capital by 450 million ordinary shares. These changes are expected to impact the company’s governance and financial structure, potentially affecting its market positioning and stakeholder interests.
On September 25, 2025, Wearable Devices Ltd. announced the execution of a Sales Agreement with A.G.P./Alliance Global Partners, allowing the company to offer and sell up to $7.4 million of its ordinary shares. The proceeds from these sales are intended for working capital and general corporate purposes. This strategic move is expected to enhance the company’s financial flexibility and support its operational goals, potentially strengthening its position in the wearable technology market.
Wearable Devices Ltd. has announced an Annual and Special General Meeting of Shareholders scheduled for October 24, 2025. The meeting’s agenda includes re-appointing auditors and directors, approving private placements of warrants, amendments to compensation policies, and discussing financial statements. These proposals, if approved, could impact the company’s governance and financial strategies, potentially influencing its market positioning and stakeholder interests.